You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES
  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  1. 1
  2. 2
  3. 3

News

CORPORATE

KEDPLASMA GmbH changes its name to Kedrion Biopharma GmbH

Further step towards an even stronger focus on patients in Europe

read more 

PLASMA & BIOTHERAPIES

First and Only US Pediatric human rabies Immune globulin Trial

Kedrion-Kamada Announce Study Met Its Primary Objective

read more 

2019
ANNUAL REPORT

Kedrion hilite image
Kedrion hilite image
Kedrion hilite image

OPEN INNOVATION